SOUTH SAN FRANCISCO, CA, October 23, 2026 – Star Therapeutics, a biotechnology company focused on the discovery and development of life-changing therapies for diseases with significant unmet need, today announced a $200 million private financing. The financing follows the July 2026 acquisition of Star subsidiary… The post Star Therapeutics Announces $200 Million Private Financing to Advance Pipeline of Best-in-Disease Therapies appeared first on STAR Therapeutics .